News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Jack O’Meara

Advertisement

CEO & Co-Founder, Ochre Bio

Articles by Jack O’Meara

A New Era in European Life Sciences Investment

ByJack O’Meara
June 6th 2022

Investments setting up sector for future success that could one day rival its US counterpart.

Advertisement

Latest Updated Articles

  • A New Era in European Life Sciences Investment
    A New Era in European Life Sciences Investment

    June 6th 2022



Advertisement
Advertisement

Trending on PharmExec

1

Lessons Learned in the Current Biotech Funding Environment

2

The Long Wait for Rare Disease Treatment Approval: Q&A with Dr. Patricia E. Greenstein

3

Regeneron Agrees to Lower Drug Costs for U.S. Patients and Provide Otarmeni for Free

4

AbbVie Invests $1.4 Billion into New Manufacturing Campus in North Carolina

5

FDA Issues CRL to AbbVie for TrenibotulinumtoxinE’s Biologics License Application

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us